APOD
APODgeneAPOD deficiency impairs HDL-mediated lipid homeostasis and anti-inflammatory signaling, promoting lipid retention and plaque inflammation.
Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationaleHDL component and lipid carrier; downregulation reduces reverse cholesterol transport and anti-inflammatory capacity.
Also acts inVascular inflammation, Systemic / off-pathway
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000189058
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(2)
- Genome-wide transcriptome study using deep RNA sequencing for myocardial infarction and coronary artery calcification.BMC medical genomics · 2021 · PMID 33568140 · doi
- Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury.Molecular & cellular proteomics : MCP · 2016 · PMID 27234505 · doi